study_id,year,design,effect_type,effect_point,ci_low,ci_high,n_treat,n_ctrl,risk_of_bias,doi,journal_id,outcome,population,adverse_events,duration_weeks
MUSC-MSK05-01,2010,randomized controlled trial,SMD,0.1908,0.019,0.3626,94,80,some concerns,10.1234/musc-msk05-01,musculoskeletal-journal-01,joint_health,Adults with joint health concerns,None reported,9
MUSC-MSK05-02,2015,randomized controlled trial,SMD,0.1854,0.0312,0.3396,77,94,mixed,10.1234/musc-msk05-02,musculoskeletal-journal-02,joint_health,Adults with joint health concerns,Transient headache,8
MUSC-MSK05-03,2020,randomized controlled trial,SMD,0.18,0.0434,0.3166,90,79,mixed,10.1234/musc-msk05-03,musculoskeletal-journal-03,joint_health,Adults with joint health concerns,Mild GI discomfort,13
